Mason Carrico Score: 48
Analyst at
Stephens
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+16.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
67%
4 W / 2 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
100%
4 W / 0 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
25%
1 W / 3 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 4 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
75%
3 W / 1 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
67%
4 W / 2 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 |
Pacific Biosciences of California Inc
PACB
|
BUY |
$2.50
Est. +22%
|
$2.05 | $3.07 |
Target Met
|
$2.57
+25.3%
|
| Aug 12, 2026 |
10x Genomics Inc - Ordinary Shares - Class A
TXG
|
BUY |
$65.00
Est. +11%
|
$58.34 | $102.81 |
Target Met
|
$67.52
+15.7%
|
| Apr 17, 2024 |
Caredx Inc
CDNA
|
BUY |
$15.00
Est. +81%
|
$8.29 | $34.84 |
Target Met
|
$85.86
+935.7%
|
| Aug 21, 2023 |
Neogenomics Inc.
NEO
|
BUY |
$18.00
Est. +28%
|
$14.08 | $18.28 |
Precision Hit (±3%)
|
$17.15
+21.8%
|
| Oct 05, 2022 |
Myriad Genetics, Inc.
MYGN
|
BUY |
$22.00
Est. +6%
|
$20.82 | - | - |
$6.01
-71.2%
|
| Oct 05, 2022 |
Guardant Health Inc
GH
|
BUY |
$99.00
Est. +66%
|
$59.78 | - | - |
$168.58
+182.0%
|
Pacific Biosciences of California Inc
PACB
Oct 23, 2026
Signal & Target
BUY
$2.50
Start Price
$2.05
Best Price (1Y)
$3.07
Current Price
$2.57
Return
+25.3%
10x Genomics Inc - Ordinary Shares - Class A
TXG
Aug 12, 2026
Signal & Target
BUY
$65.00
Start Price
$58.34
Best Price (1Y)
$102.81
Current Price
$67.52
Return
+15.7%
Caredx Inc
CDNA
Apr 17, 2024
Signal & Target
BUY
$15.00
Start Price
$8.29
Best Price (1Y)
$34.84
Current Price
$85.86
Return
+935.7%
Neogenomics Inc.
NEO
Aug 21, 2023
Signal & Target
BUY
$18.00
Start Price
$14.08
Best Price (1Y)
$18.28
Current Price
$17.15
Return
+21.8%
Myriad Genetics, Inc.
MYGN
Oct 05, 2022
Signal & Target
BUY
$22.00
Start Price
$20.82
Best Price (1Y)
-
Current Price
$6.01
Return
-71.2%
Guardant Health Inc
GH
Oct 05, 2022
Signal & Target
BUY
$99.00
Start Price
$59.78
Best Price (1Y)
-
Current Price
$168.58
Return
+182.0%